Key result
Prosteatotic PNPLA3 p.148Met/Met genotype linked to higher serum ALT vs p.148Ile/Ile in children.
Why the study?
The association of the common adiponutrin (PNPLA3) variant p.Ile148Met with hepatic and metabolic traits in a pediatric cohort was investigated due to its link with liver injury.
Is the PNPLA3 variant p.Ile148Met associated with early liver injury in children?
Cohort (n=142)
Is the PNPLA3 variant p.Ile148Met associated with early liver injury in children?
The PNPLA3 variant p.Ile148Met is associated with increased serum ALT activities in children, indicating early liver injury.
May indicate early liver injury in pediatric PNPLA3 variant carriers; leaves open prospective validation before clinical use.
Introduction. The common adiponutrin (PNPLA3) variant p.Ile148Met is associated with liver injury. Here, we investigate the association of this polymorphism with hepatic and metabolic traits in a pediatric cohort. Patients and Methods. The study cohort comprised 142 German children (age 5-9 years, 98 overweight, 19 children with NAFLD). Results. Overweight children presented with increased serum ALT (P = 0.001) and GGT (P < 0.001) activities. ALT activities differed significantly (P = 0.02) between carriers of different PNPLA3 genotypes in the entire study cohort, in normal weight children (P = 0.02) and in children younger than 7 years (P = 0.02). Carriers of the prosteatotic PNPLA3 genotype p.148Met/Met displayed higher ALT activities as compared to children with the frequent genotype p.148Ile/Ile (P = 0.01). The BMI was however a stronger predictor of ALT activities compared to the PNPLA3 genotype (P < 0.001 and P = 0.06, resp.). The variant was associated with increased serum glucose levels (P = 0.01) and HOMA index (P = 0.02) in carriers of the p.148Ile/Met genotype but did not affect other metabolic traits or the presence of NAFLD. Discussion. The frequent PNPLA3 variant p.Ile148Met is associated with serum ALT activities already at a young age.
No takes yet. Share an insight, caveat, or question.
Krawczyk et al. (2015) conducted a cohort in Liver injury (n=142). PNPLA3 variant p.Ile148Met vs. PNPLA3 genotype p.148Ile/Ile was evaluated on Serum ALT activities (p=0.01). The prosteatotic PNPLA3 genotype p.148Met/Met was associated with higher serum ALT activities compared to the frequent genotype p.148Ile/Ile in children (P=0.01).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: